Description
Semaglutide
Chemical Classification: GLP-1 Receptor Agonist (Incretin Mimetic)
Research Overview
Semaglutide is a synthetic 31-amino acid peptide analog of the naturally occurring human glucagon-like peptide-1 (GLP-1). In biochemical research, it is classified as a long-acting incretin mimetic. It is engineered with a specific fatty acid side chain and a spacer, which enhances its affinity for albumin and significantly increases its half-life by resisting degradation by the enzyme dipeptidyl peptidase-4 (DPP-4). Semaglutide is a primary subject in studies exploring the potentiation of glucose-dependent insulin secretion and the modulation of central appetite signaling.
Common Research Applications
This GLP-1 receptor agonist is frequently utilized in laboratory models to investigate the following experimental objectives:
- Incretin System Dynamics:Research focusing on the stimulation of pancreatic beta-cell insulin secretion and the simultaneous suppression of alpha-cell glucagon release.
- Gastric Motility Modulation:Investigations into the rate of gastric emptying and the subsequent impact on postprandial glucose fluctuations in non-human models.
- Hypothalamic Satiety Regulation:Studies regarding the peptide’s interaction with the arcuate nucleus of the hypothalamus to investigate mechanisms of appetite suppression and energy intake.
- Cardiovascular Protective Signaling:Exploration of the peptide’s influence on vascular endothelial function and its impact on systemic inflammatory markers such as C-reactive protein (CRP).
- Neuroprotective Research:Emerging studies investigating the potential of GLP-1 analogs to modulate neuroinflammation and protein aggregation in models of cognitive decline.
Laboratory Handling & Storage
- Appearance:Lyophilized white powder.
- Solubility:Highly soluble in bacteriostatic water, or sterile saline.
Stability: Stable at room temperature for transit. For long-term preservation, the lyophilized powder must be stored at -20°C.